TSLA
Tesla
-- 424.210 NVDA
NVIDIA
-- 136.820 PLTR
Palantir
-- 73.900 AMD
Advanced Micro Devices
-- 130.045 GOOG
Alphabet-C
-- 194.510 
Jiangsu CoWin Biotech's high P/S ratio may be unjustified du...
Jiangsu CoWin Biotech's high P/S ratio may be unjustified due to its poor financial performance and declining revenue. If the company's medium-term revenue trends persist, it could pose a risk to the share price and potential investors.
Jiangsu CoWin Biotech Co., Ltd.'s (SHSE:688426) 37% Share Price Plunge Could Signal Some Risk
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment